Download PDF
Arzneimittelforschung 2010; 60(10): 627-635
DOI: 10.1055/s-0031-1296337
Antibiotics · Antimycotics · Antiparasitics · Antiviral Drugs · Chemotherapeutics · Cytostatics
Editio Cantor Verlag Aulendorf (Germany)

Synthesis, cytotoxicity and antimalarial activity of ferrocenyl amides of 4-aminoquinolines

D N’Da David
1   Pharmaceutical Chemistry, North-West University, Potchefstroom, South Africa
,
C Breytenbach Jaco
1   Pharmaceutical Chemistry, North-West University, Potchefstroom, South Africa
,
J Smith Peter
2   Pharmacology, University of Cape Town, Groote Schuur Hospital, Observatory, South Africa
,
Carmen Lategan
2   Pharmacology, University of Cape Town, Groote Schuur Hospital, Observatory, South Africa
› Author Affiliations
Further Information

Publication History

Publication Date:
03 December 2011 (online)

    Permissions and Reprints

Abstract

Series of 4-aminoquinolines bearing an amino side chain linked to the ferrocene moiety through an amide bond were synthesized and evaluated for their antimalarial activity against both chloro-quine-sensitive (D10, CQ-S) and chloro-quine-resistant (Dd2, CQ-R) strains of Plasmodium falciparum. They were also tested for cytotoxicity against Chinese Hamster Ovarian (CHO) cells. Amide 12 featuring propyl side chain linked to the ferrocene ring was the most active of all tested compounds. With an IC50 value of 0.08 µg/mL, this amide showed 1.5-fold higher activity than chloroquine diphosphate (IC50 = 0.12 µg/mL) against the resistant strain, with a selectivity index of 550 indicating its high selectivity towards the parasite. Derivatives which were equipotent against both strains also showed up to ten-fold increase in activity compared to primaquine.

Key words

4-Aminoquinolines - Antimalarial activity - Cytotoxicity - Ferrocene - Plasmodium falciparum
 

  • References

  • 1 Jung M, Li X, Bustos DA, Elsohly HN, McChesney JD, Mil-hous WK. Synthesis activity of (+)-deoxyartemisinin. J Med Chem. 1990; 33: 1516-8
    CrossrefPubMedGoogle Scholar
  • 2 Payne D. Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum?. Parasitol Today. 1988; 4: 112-115
    CrossrefPubMedGoogle Scholar
  • 3 Peters W. Chemotherapy and Drug Resistance in Malaria. 2nd ed. Academic Press:; London: 1987
    Google Scholar
  • 4 Cherfas J. Malaria vaccines: the failed promise. Science. 1990; 247: 402-3
    CrossrefPubMedGoogle Scholar
  • 5 Cowden WB, Halladay PK, Cunningham RB, Hunt NH, Clark IA. Flavins as potential antimalarials. 2. 3-Methyl-lO-(substituted-phenyl) flavins. J Med Chem. 1991; 34: 1818-22
    CrossrefPubMedGoogle Scholar
  • 6 Dubar F, Anquetin G, Pradines B, Dive D, Khalife J, Biot C. Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug/biorganometallic approach. J Med Chem. 2009; 52: 7954-7
    CrossrefPubMedGoogle Scholar
  • 7 Gao LM, Hernández R, Matta J, Meléndez E. Synthesis, structure, electrochemistry, and cytotoxic properties of ferrocenyl ester derivatives. Met Based Drugs. 2009 March 24. doi: 10.1155/2009/420784. PubMed Central PMCID: PMC2659881.
    PubMed
  • 8 Osella D, Ferrali M, Zanello P, Laschi F, Fontani M, Carlo N et al. On the mechanism of the antitumor activity of ferrocenium derivatives. Inorg Chim Acta. 2000; 306: 42-8
    CrossrefPubMedGoogle Scholar
  • 9 Mokdsi G, Harding MM. Inhibition of human topoisomerase II by the antitumor metallocenes. J Inorg Biochem. 2001; 83: 205-9
    CrossrefPubMedGoogle Scholar
  • 10 Dombrowski KE, Baldwin W, Sheats JE. Metallocenes in biochemistry, microbiology and medicine. J Organomet Chem. 1986; 302: 281-306
    CrossrefPubMedGoogle Scholar
  • 11 Togni A, Hayashi T. editors. Ferrocenes: homogeneous catalysis, organic synthesis, materials science. Weinheim (Germany): Wiley-VCH; 1995
    Google Scholar
  • 12 Arrayas RG, Adrio J, Carretero JC. Recent applications of chiral ferrocene ligands in asymmetric catalysis. Angew Chem Int Ed. 2006; 45: 7674-715
    CrossrefPubMedGoogle Scholar
  • 13 Atkinson RCJ, Gibson VC, Long NJ. The syntheses and catalytic applications of unsymmetrical ferrocene ligands. Chem Soc Rev. 2004; 33: 313-328
    CrossrefPubMedGoogle Scholar
  • 14 Top S, Tang J, Vessieres A, Carrez D, Provot C, Jaouen G. Ferrocenyl hydroxytamoxifen: a prototype for a new range of oestradiol receptor site-directed cytotoxics. Chem Commun. 1995: 995-6
    Google Scholar
  • 15 Motohashi N, Meyer R, Gollapudi SR, Bhattiprolu KR. Synthesis and activity of potential antitumor ferrocenes. J Organomet Chem. 1990; 398: 205-217
    CrossrefPubMedGoogle Scholar
  • 16 Biot C, Francois N, Maciejewski L, Brocard J, Poulain D. Synthesis and antifungal activity of a ferrocene-fluconazole analogue. Biorg Med Chem Let. 2000; 10: 839-41
    PubMedGoogle Scholar
  • 17 Itoh T, Shirakami S, Ishida N, Yamashita Y, Yoshid T, Kimb HS et al. Synthesis of novel ferrocenyl sugars and their antimalarial activities. Biorg Med Chem Let. 2000; 10: 1657-9
    PubMedGoogle Scholar
  • 18 Biot C, Glorian G, Maciejewski LA, Brocard JS, Domarle O, Blampain G et al. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue. J Med Chem. 1997; 40: 3715-8
    CrossrefPubMedGoogle Scholar
  • 19 Chim P, Lim P, Sem R, Nhem S, Maciejewski L, Fandeur L. The in-vitro antimalarial activity of ferrochloroquine measured against Cambodian isolates of Plasmodium falciparum. Ann Trop Med Parasitol. 2004; 98: 419-24
    CrossrefPubMedGoogle Scholar
  • 20 Domarle O, Blampain G, Agnaniet H, Lebibi J, Brocard J, Maciejewski L et al. In vitro antimalarial activity of a new organometallic analog, ferroquine-chloroquine. Antimicrob Agents Chemother. 1998; 42: 540-4
    PubMedGoogle Scholar
  • 21 http://clinicaltrials.org/ct2/show/NCT00563914
    PubMed
  • 22 Biot C, Delhaes L, Maciejewski LA, Mortuaire M, Camus D, Dive D et al. Synthetic ferrocenic mefloquine and quinine analogues as potential antimalarial agents. Eur J Med Chem. 2000; 35: 707-14
    CrossrefPubMedGoogle Scholar
  • 23 Beagley P, Blaclie MAL, Chibale K, Clarkson C, Meijboom R, Moss JR et al. Synthesis and antiplasmodial activity in vitro of new ferrocene-chloroquine analogues. Dalton Trans. 2003; 3046-51
    PubMedGoogle Scholar
  • 24 Top S, Vessieres A, Cabestaing C, Laios I, Leclercq G, Provot C et al. Studies on organometallic selective receptor modulators (SERMs). Dual activity in the hydroxy-ferrocifen series. J Organomet Chem. 2001; 637–639: 500-6
    PubMedGoogle Scholar
  • 25 Wu X, Tiekink ERT, Kostetski I, Kocherginski N, Tan ALC, Khoo SB et al. Antiplasmodial activity of ferrocenyl chalcones: investigations into the role of ferrocene. Eur J Pharm Sci. 2006; 27: 175-87
    CrossrefPubMedGoogle Scholar
  • 26 Biot C, Daher W, Ndiaye CM, Melnyk P, Pradines B, Chavain N et al. Probing the role of the covalent linkage of ferrocene into a chloroquine template. J Med Chem. 2006; 49: 4707-17
    CrossrefPubMedGoogle Scholar
  • 27 Gagnon P, Huang Xicai, Themen E, Keillor JW. Peptide coupling of unprotected amino acids through in situ p-nitrophenyl ester formation. Tetrahedron Let. 2002; 43: 7717-9
    CrossrefPubMedGoogle Scholar
  • 28 Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976; 193: 673-6
    CrossrefPubMedGoogle Scholar
  • 29 Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg. 1993; 48: 739-42
    CrossrefPubMedGoogle Scholar
  • 30 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65: 55-63
    CrossrefPubMedGoogle Scholar
  • 31 Rubinstein LV, Shoemaker RH, Pauli KD, Simon RM, Tosini S, Skehan P et al. Comparison of in vitro anticancer-drugscreening data generated with a tetrazolium assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst. 1990; 82: 1113-8
    CrossrefPubMedGoogle Scholar
  • 32 Swarts JC, Neuse EW, Lamprecht GJ. Synthesis and characterization of water-soluble polyaspartamide-ferrocene conjugates for biomedical application. J Inorg Organomet Polym. 1994; 4: 143-53
    CrossrefPubMedGoogle Scholar
  • 33 De D, Krogstad FM, Byers LD, Krogstad DJ. Structure-activity relationships for antiplasmodial activity among 7-sub-stituted 4-aminoquinolines. J Med Chem. 1998; 41: 4918-26
    CrossrefPubMedGoogle Scholar
  • 34 Biot C, Taramelli D, Forfar-Bares I, Maciejewski LA, Boyce M, Nowogrocki G, Brocard JS, Basilicao N, Olliaro P, Egan TJ. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Mol Pharm. 2005; 2: 185-93
    CrossrefPubMedGoogle Scholar
  • 35 Delarue-Cochin S, Grellier P, Maes L, Mouray E, Sergheraet C, Melnyk P. Synthesis and antimalarial activity of carbamate and amide derivatives of 4-anilinoquinoline. Eur J Med Chem. 2008; 43: 2045-55
    CrossrefPubMedGoogle Scholar
  • 36 Lin C, Feny-yi Q, Yan-chang Z. Field observations on the antimalarial piperaquine. Chin Med J. 1982; 95: 281-6
    PubMedGoogle Scholar
  • 37 Lin C. Recent studies on the antimalarial efficacy of piperaquine and hydroxypiperaquine. Chin Med J. 1991; 104: 161-4
    PubMedGoogle Scholar